Every dollar amount and date on this page is quoted from the official settlement document.
Generic Drugs End-Payer Antitrust Settlement
Court case: In re Generic Pharmaceuticals Antitrust Litigation, No. 16-MD-2724
Three court-approved settlements with generic drug makers — Sandoz, Sun/Taro, and Heritage/Apotex — resolve claims that manufacturers fixed prices on common prescription generics. If you paid for covered generic drugs between May 2009 and December 2019, you may be able to claim a share of the settlement funds.
Official eligibility wordingYou may be eligible if you are a person or entity in any of the 50 United States (except Indiana and Ohio), the District of Columbia, Puerto Rico, or the U.S. Virgin Islands that indirectly purchased, paid, and/or provided reimbursement for some or all of the purchase price of any Named Generic Drugs (list posted on the settlement site), other than for resale, from May 1, 2009 through December 31, 2019. Consumers file under the Sandoz and/or Sun/Taro settlement classes (third-party payers may also file under the Apotex and Heritage settlements); defendants and their affiliates, federal governmental entities, and those who only purchased at wholesale or directly from defendants are excluded. Checked against the official settlement source by SettleSignal on October 25, 2026.
Key facts
- Who may qualify You may be eligible if you live in any of the 50 U.S. states (except Indiana and Ohio), D.C., Puerto Rico, or the U.S. Virgin Islands and you paid for or reimbursed any of the Named Generic Drugs (not for resale) — check the official drug list to see if your prescription is covered.
- Estimated payoutCourt-approved settlement funds: a settlement with Sandoz Inc. and Fougera Pharmaceuticals Inc.; a settlement with Sun Pharmaceutical Industries, Inc. and Taro Pharmaceuticals U.S.A., Inc.; and two settlements with Heritage Pharmaceuticals Inc., Emcure Pharmaceuticals Ltd., Satish Mehta, and Apotex Corp. Class members file a claim for a share of the settlement funds; the amount and timing of payment are based on the Court-approved Plan of Allocation and the total dollar amount you paid for Named Generic Drugs.
- Claim deadlineNovember 9, 2026
- Proof requiredOptional
- What you needClaim form online or by mail, postmarked by November 9, 2026 — you report the total dollar amount you paid for Named Generic Drugs; no documents required upfront, though the Claims Administrator may request supporting records and claims can be audited.
- CourtUnited States District Court for the Eastern District of Pennsylvania
Verify it yourself
How we verified this record
The key facts on this page were taken from the official settlement source, and last checked on October 25, 2026. We re-verify each field individually on a weekly pass.
1 official source linked to this record.
Where to act
File directly with the official administrator via the official claim form before November 9, 2026.
